Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2019 | When is allogeneic transplant the right answer for MM?

Gösta Gahrton • 15 Sep 2019
IMW 2019
Multiple Myeloma

Gösta Gahrton, MD, of Karolinska University Hospital, Stockholm, Sweden, discusses when is allogeneic transplant the right answer for patients with myeloma. Recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

More from Gösta Gahrton

3:43
The role of allo-HSCT in treating relapsed patients with multiple myeloma
Gösta Gahrton • 13 Oct 2021
1:12
Promising outlook for MM patients
Gösta Gahrton • 12 Sep 2019

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals